|
Abortion, Tubal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
|
Acute Erythroblastic Leukemia
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Effect of nitric oxide on expression of transferrin receptor and ferritin and on cellular iron metabolism in K562 human erythroleukemia cells.
|
7742556 |
1995 |
|
Acute Erythroblastic Leukemia
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Effect of aluminium on iron uptake and transferrin-receptor expression by human erythroleukaemia K562 cells.
|
2268267 |
1990 |
|
Acute Erythroblastic Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
CD71 may not be a specific marker for AEL leukemic cells.
|
23962073 |
2014 |
|
Acute Erythroblastic Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
Finally, a short hairpin RNA study showed that FUT8 down-regulation induced hemoglobin production and increase of transferrin receptor/glycophorin A-positive cells in human erythroleukemia K562 cells.
|
23609441 |
2013 |
|
Acute infectious disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Here we show that acute infection by the New World Junin virus (JUNV) failed to down-regulate the transferrin receptor and did not induce superinfection exclusion.
|
26549784 |
2015 |
|
Acute leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia.
|
23962073 |
2014 |
|
Acute lymphocytic leukemia
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
CD71 expression was significantly higher on T- ALL patients compared with B-ALL patients.
|
29875008 |
2018 |
|
Acute lymphocytic leukemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Microfluidic Separation of Lymphoblasts for the Isolation of Acute Lymphoblastic Leukemia Using the Human Transferrin Receptor as a Capture Target.
|
28656755 |
2017 |
|
Acute Megakaryocytic Leukemias
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In the seven cases of acute erythroid leukemia (AEL), leukemic cells rarely expressed CD71, with the mean CD71 expression level significantly lower than that of acute megakaryocytic leukemia (p < 0.05), and also lower than that of poorly differentiated AML and normal blasts but without statistical significance.
|
23962073 |
2014 |
|
Acute monocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Poorly differentiated acute myeloid leukemias (AMLs) (including minimally differentiated AML, AML without maturation, AML with maturation, acute myelomonocytic leukemia) tended to express high levels of CD71 on leukemic cells, while partially differentiated AML (including acute promyelocytic leukemia and acute monocytic leukemia) often expressed low levels of CD71 on leukemic cells (p < 0.05, compared to poorly differentiated AML).
|
23962073 |
2014 |
|
Acute myelomonocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Poorly differentiated acute myeloid leukemias (AMLs) (including minimally differentiated AML, AML without maturation, AML with maturation, acute myelomonocytic leukemia) tended to express high levels of CD71 on leukemic cells, while partially differentiated AML (including acute promyelocytic leukemia and acute monocytic leukemia) often expressed low levels of CD71 on leukemic cells (p < 0.05, compared to poorly differentiated AML).
|
23962073 |
2014 |
|
Acute pancreatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Soluble transferrin receptor was not significantly associated with chronic hyperglycaemia after acute pancreatitis.
|
28836100 |
2018 |
|
Acute Promyelocytic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Poorly differentiated acute myeloid leukemias (AMLs) (including minimally differentiated AML, AML without maturation, AML with maturation, acute myelomonocytic leukemia) tended to express high levels of CD71 on leukemic cells, while partially differentiated AML (including acute promyelocytic leukemia and acute monocytic leukemia) often expressed low levels of CD71 on leukemic cells (p < 0.05, compared to poorly differentiated AML).
|
23962073 |
2014 |
|
Acute-Phase Reaction
|
0.200 |
Biomarker
|
phenotype |
RGD |
Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the rat.
|
17417667 |
2007 |
|
Adenocarcinoma of lung (disorder)
|
0.030 |
Biomarker
|
disease |
BEFREE |
In addition, our results suggest a new method for blocking the signal from the oncogene KRAS by targeting TfR in LAC.
|
29286585 |
2018 |
|
Adenocarcinoma of lung (disorder)
|
0.030 |
Biomarker
|
disease |
BEFREE |
Finally, a sensitive and specific diagnostic panel comprising CDKN2A, CX3CR1, COX4I2, SLC15A2 and TFRC genes were identified for early detection of Lung Adenocarcinoma.
|
31843580 |
2020 |
|
Adenocarcinoma of lung (disorder)
|
0.030 |
Biomarker
|
disease |
BEFREE |
Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin.
|
27236820 |
2016 |
|
Adenocarcinoma of pancreas
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, miR-7 expression was inversely correlated with TfR1 mRNA in human pancreatic adenocarcinoma patient samples.
|
29295890 |
2018 |
|
Adenoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
In the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, 679 persons with advanced distal adenoma and 697 control persons were genotyped for the two major HFE mutations (C282Y and H63D), one HFE polymorphism (IVS2+4), and one polymorphism (G142S) in the transferrin receptor gene (TFRC).
|
15668490 |
2005 |
|
Adrenoleukodystrophy
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
At the mRNA level, expressions of DMT1, FPN1 and TFR1 genes were significantly increased in ALD.
|
24894955 |
2014 |
|
Adult Acute Lymphocytic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CD71 expression was significantly higher on T- ALL patients compared with B-ALL patients.
|
29875008 |
2018 |
|
Adult Acute Monocytic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Poorly differentiated acute myeloid leukemias (AMLs) (including minimally differentiated AML, AML without maturation, AML with maturation, acute myelomonocytic leukemia) tended to express high levels of CD71 on leukemic cells, while partially differentiated AML (including acute promyelocytic leukemia and acute monocytic leukemia) often expressed low levels of CD71 on leukemic cells (p < 0.05, compared to poorly differentiated AML).
|
23962073 |
2014 |
|
Adult Acute Myelomonocytic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Poorly differentiated acute myeloid leukemias (AMLs) (including minimally differentiated AML, AML without maturation, AML with maturation, acute myelomonocytic leukemia) tended to express high levels of CD71 on leukemic cells, while partially differentiated AML (including acute promyelocytic leukemia and acute monocytic leukemia) often expressed low levels of CD71 on leukemic cells (p < 0.05, compared to poorly differentiated AML).
|
23962073 |
2014 |
|
Adult Burkitt Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Other activation antigens were unaffected by EBNA-2 expression, as were markers already expressed on the parent BL cell line, including BL markers (cALLA and BLA), proliferation markers (transferrin receptor and BK19.9), and cell adhesion-related molecules (LFA-1 and LFA-3).
|
3033649 |
1987 |